Encodia is developing an innovative Next-Gen digital proteomics platform to enable democratized protein sequencing.
Our goal is to make protein sequencing easy and ubiquitous by using a novel reverse-translation technology that turns peptide sequences into DNA. The DNA can be read by an NGS DNA sequencer, providing a path to breakthrough proteomics research at a scale that is not practical or cost-effective using current technologies.
Location: United States, California, San Diego
Employees: 51-200
Total raised: $75M
Founded date: 2015
Investors 1
Date | Name | Website |
17.07.2021 | ARCH Ventu... | archventur... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
12.02.2021 | Series C | $75M | - | citybizlis... |
Mentions in press and media 7
Date | Title | Description | Source |
02.11.2021 | Slone Partners Places Nigel Beard Ph.D. as Chief Technology ... | SOUTH RIDING, Va. (PRWEB) November 02, 2021 Slone Partners, a nationwide executive search firm for ... | prweb.com/... |
12.02.2021 | Encodia Closes $75M Series C Financing | - | archventur... |
29.01.2021 | Encodia Gets $75M In Series C | San Diego-based Encodia, a biotech company which is focused on proteomics research, has raised $75M ... | socaltech.... |
28.01.2021 | Encodia Raises $75M in Series C Financing | Encodia, a San Diego, CA-based biotech company developing next-generation solutions for proteomics r... | citybizlis... |
28.01.2021 | Encodia Raises $75M in Series C Financing | Encodia, a San Diego, CA-based biotech company developing next-generation solutions for proteomics r... | finsmes.co... |
27.01.2021 | Encodia Closes $75M Series C Financing Led by Northpond Vent... | SAN DIEGO, Jan. 27, 2021 /PRNewswire/ -- Encodia, a privately held biotech company developing next... | prnewswire... |
27.01.2021 | Encodia has closed a $75M Series C round to accelerate the p... | - | connect.or... |